共 1035 条
[1]
The L(2018)GLOBOCAN 2018: Counting the toll of cancer Lancet (London, England) 392 985-202
[2]
Asano Y(2020)Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes Molecular and clinical oncology 13 195-113
[3]
Kashiwagi S(2010)Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer J Clin Oncol 28 105-62
[4]
Goto W(2017)Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: A retrospective analysis of the CLEOPATRA study The Lancet. Oncology 18 52-82
[5]
Takada K(2019)Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: A phase 1 study JAMA Oncology 5 74-320
[6]
Takahashi K(2018)Relationship between tumor infiltrating lymphocytes and progression in breast cancer Maedica 13 317-1466
[7]
Shibutani M(1992)Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer Anticancer Res 12 1463-189
[8]
Denkert C(2019)Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer Breast Cancer 26 180-632
[9]
Loibl S(2013)FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis Molecular and clinical oncology 1 625-252
[10]
Noske A(1998)Dendritic cells and the control of immunity Nature 392 245-266